drugset / Trial / NCT00000344

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

NCT00000344 ↗

Phase 2 Completed 40 enrolled National Institute on Drug Abuse (NIDA)
RandomizedDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.

Timeline

Start
—
Primary completion
—
Completion
2000-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine/naloxone Unknown — Other

Indications